BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10107391)

  • 1. Drug usage evaluation of aminoglycoside-induced nephrotoxicity in a community hospital.
    Wade WE; McCall CY
    Hosp Formul; 1990 Oct; 25(10):1092-4, 1096. PubMed ID: 10107391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective audit of an aminoglycoside consultative service in a general hospital.
    Li SC; Ioannides-Demos LL; Spicer WJ; Spelman DW; Tong N; McLean AJ
    Med J Aust; 1992 Sep; 157(5):308-11. PubMed ID: 1435470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A practical approach enabling staff pharmacists to prospectively review and dose aminoglycoside therapy.
    Possidente CJ; Lynch T
    Hosp Pharm; 1988 Nov; 23(11):976-8, 981-3. PubMed ID: 10290757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglycoside utilization study.
    Haslett TM; Reynolds JR
    Hosp Pharm; 1988 Oct; 23(10):872, 874-5, 878-80. PubMed ID: 10290108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-benefit analysis of an aminoglycoside monitoring service.
    Kimelblatt BJ; Bradbury K; Chodoff L; Aggour T; Mehl B
    Am J Hosp Pharm; 1986 May; 43(5):1205-9. PubMed ID: 3087162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous aminoglycoside usage and monitoring of patients with cystic fibrosis in Australia. What's new?
    Soulsby N; Bell S; Greville H; Doecke C
    Intern Med J; 2009 Aug; 39(8):527-31. PubMed ID: 19220547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimizing aminoglycoside toxicity by prescriber notification of prolonged therapy.
    Brown G
    Hosp Pharm; 1995 Jan; 30(1):33-6. PubMed ID: 10139728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of aminoglycoside-use restrictions on drug cost.
    DeTorres OH; White RE
    Am J Hosp Pharm; 1984 Jun; 41(6):1137-9. PubMed ID: 6430070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of a once-daily aminoglycoside program in a large community-teaching hospital.
    Nicolau DP; Belliveau PP; Nightingale CH; Quintiliani R; Freeman CD
    Hosp Pharm; 1995 Aug; 30(8):674-6, 679-80. PubMed ID: 10144645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial pharmacokinetic dosing of aminoglycosides: a community hospital experience.
    Hoffa DE
    Ther Drug Monit; 1989 Sep; 11(5):574-9. PubMed ID: 2815234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoglycoside monitoring program.
    Vakoutis J; Stein GE; Miller PB; Clayman AE
    Am J Hosp Pharm; 1981 Oct; 38(10):1477-80. PubMed ID: 7294041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycoside nephrotoxicity: keys to prevention.
    Levin ML
    J Crit Illn; 1994 Oct; 9(10):911-2, 915. PubMed ID: 10150695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycosides--50 years on.
    Begg EJ; Barclay ML
    Br J Clin Pharmacol; 1995 Jun; 39(6):597-603. PubMed ID: 7654476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of an aminoglycoside kinetic service on aminoglycoside use in a community hospital.
    Cahill RJ; Myers RM; Bauer LA; Alston RM
    Hosp Pharm; 1986 Aug; 21(8):734-7. PubMed ID: 10277582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An aminoglycoside monitoring service in a community hospital using a microcomputer.
    Voytovich RM; Outten RL
    Hosp Pharm; 1987 Mar; 22(3):267-72. PubMed ID: 10281372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis.
    Graham AC; Mercier RC; Achusim LE; Pai MP
    Ann Pharmacother; 2004 Jun; 38(6):936-41. PubMed ID: 15084688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of pharmacy intervention on aminoglycoside costs.
    Tsuyuki RT; Nakagawa RS
    Can J Hosp Pharm; 1987 Apr; 40(2):51-6. PubMed ID: 10282090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Justification and evaluation of an aminoglycoside pharmacokinetic dosing service.
    Jorgenson JA; Rewers RF
    Hosp Pharm; 1991 Jul; 26(7):605, 609-11, 615. PubMed ID: 10111793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors potentially influencing aminoglycoside use and expenditure.
    DiPiro JT; Kilsdonk GF; Amerson AB; Record KE
    Am J Hosp Pharm; 1982 Jul; 39(7):1180-3. PubMed ID: 7114060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoglycoside usage in a university teaching hospital.
    Noble MA; Lloyd N; Andrews D; Bernstein M; Sacks S
    Can J Hosp Pharm; 1986 Aug; 39(4):88-91. PubMed ID: 10278472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.